openPR Logo
Press release

Hepatitis E Diagnostic Tests Market Estimated to Cross US$60.4 Mn by 2024

08-14-2018 07:48 PM CET | Health & Medicine

Press release from: Transparency Market Research

Hepatitis E Diagnostic Tests Market Estimated to Cross US$60.4

The global Hepatitis E Diagnostic Tests Market is characterized by an intense level of competition. The strongholds of the leading players coupled with the strategic efforts of the emerging players have been the key reasons behind the cutthroat competition. Furthermore, a major share of the market was held by Beijing Wantai Biological Pharmacy in 2015, and the company is expected to stay ahead of other players over the forthcoming years. The market players that follow Beijing Wantai Biological Pharmacy in terms of market share are also expected to resort to innovative business strategies to retain their streak of excellence.

View Report -

https://www.transparencymarketresearch.com/hepatitis-e-diagnostic-tests-market.html

Strategic alliances are projected to be amongst the key highlights of the global market as several players aim to thrive by partnering with other market vendors. Moreover, the local and regional players are anticipated to concentrate on strengthening their reigns in their respective regions. In order to penetrate into the regional market, the international players are expected to resort to mergers and acquisitions. Besides this, pricing strategy has been a decisive element of the competitive landscape and is expected to keep influencing the dynamics of the market over the coming years. Some of the leading players in the global market for hepatitis E diagnostic tests are Primerdesign Ltd., Fortress Diagnostics Ltd., MP Biomedicals LLC, and Hoffmann-La Roche Ltd.

A report published by Transparency Market Research (TMR) deconstructs the elements of the global market for hepatitis E diagnostic tests. The global market is expected to cumulate a revenue of US$60.4 mn by 2024 escalating from a value of US$43.7 mn in 2015. Furthermore, the CAGR of the global hepatitis E diagnostic market is expected to settle at 3.80% over the period between 2016 and 2024. Based on the type of test, ELISA HEV IgM tests have emerged as the most popular category of tests for the detection of Hepatitis E.

Request to View Sample of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16859

Medical Awareness Campaigns to Drive Demand

Until a decade back, a large number of third-world countries were deprived of several vaccinations, treatments, and medical tests. However, in recent times, due to the efforts of the World Health Organization (WHO) and other healthcare bodies, the people within these countries now have access to better healthcare facilities. This has underhandedly contributed to the growth of the global market for hepatitis E and has created growth spaces for market players. Furthermore, the high incidence of hepatitis E across countries such as Uganda, Kenya, Nigeria, and Morocco has persuaded international bodies to institute better treatment facilities. Despite the affluent growth of the global market for hepatitis E treatment, the high incidence of asymptomatic diseases that cannot be easily diagnosed has hampered market growth.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16859

Asia Pacific to Emerge as Leading Regional Segment

The endemicity of hepatitis E across countries such as Bangladesh, Nepal, Pakistan, Kazakhstan, Bhutan, Thailand, and Vietnam has given potency to the market for hepatitis E across Asia Pacific. Moreover, the efforts of the governments across these countries to offer better healthcare facilities have also fortified the growth of the global market. Furthermore, the market for hepatitis E in North America and Europe has also treaded a positive growth path over the past years.

Enquiry for discount on this report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16859

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hepatitis E Diagnostic Tests Market Estimated to Cross US$60.4 Mn by 2024 here

News-ID: 1180508 • Views:

More Releases from Transparency Market Research

Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive AI Adoption and Next-Generation Edge Computing Innovations | TMR
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A …
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034. Examine key highlights and
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological Disease Burden Accelerates | TMR
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological …
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-has
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Innovations in Gene Editing, Stem Cell Therapy, and AI-Based Neuromedicine | TMR
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn …
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue. Examine key highlights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322 With breakthroughs
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Advances in Brain Mapping, AI, and Portable Neuroimaging | TMR
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv …
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation. Examine

All 5 Releases


More Releases for Hepatitis

POC Diagnostics Encourages Timely Hepatitis Testing Amid WHO's Hepatitis D Carci …
Birmingham, 18th September, 2025: The World Health Organization (WHO) recently classified Hepatitis D as a carcinogen and raised a global concern about its link to liver cancer. In response to this, POC Diagnostic, one of the renowned and leading providers of modern medical testing solutions, urges both individuals and healthcare providers to prioritise early Hepatitis recognition. Timely detection of Hepatitis infections is critical to prevent severe health complications. POC Diagnostics is
Driving Viral Hepatitis Market Growth in 2025: The Role of Elevated Prevalence O …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts Viral Hepatitis Market Size Growth Forecast: What to Expect by 2025? In the past few years, the size of the viral hepatitis market has experienced consistent growth. It is projected to increase from $16.21 billion in 2024 to $16.93 billion in 2025, representing a compound annual growth rate (CAGR)
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate? In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate? In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted
Hepatitis D Market - Defeating Hepatitis D Together: Uniting Against the Silent …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hepatitis D Market. Hepatitis D Market: https://www.growthplusreports.com/report/hepatitis-d-market/9196 The Hepatitis D Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.
Hepatitis C Testing Market - Advancing Hepatitis C Elimination Strategies: Embra …
Newark, New Castle, USA: The "Hepatitis C Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Hepatitis C Testing Market: https://www.growthplusreports.com/report/hepatitis-c-testing-market/7962 This latest report researches the industry structure,